维普期刊资源整合服务平台（V6.5）

292篇 您的检索式：作者名="T CONROY"

选中清除导出查看参考文献查看引证文献引用追踪共15页首页上一页第1页下一页末页 /15 跳转

	题名	作者	年代	出处	被引量
1	Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203 显示文摘	Gerard JP Conroy T Bonnetain F	2006	J Clin Oncol2006，24，28：	1
2	Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oescphagus:responese,to xicity,quality of life and survival显示文摘	Conroy T Etienne P-L A demis A	2002	Ann one2002，13，5：	1
3	Clinical and psychometric validation of an EROTC questionnsire module,the EROTC QLQ-OES18,to assess quality of life in patients with oesophageal cancer显示文摘	Blzeby JM Conroy T Hammerllid E	2003	Eur J Cancer2003，39，10：	1
4	FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer显示文摘	Conroy T Desseigne F Yehou M	2011	N Engl J Med2011，364，19：	1
5	Chemotherapy of metastatic panereatic adenoear- einoma: Challenges and encouraging results 显示文摘	Conroy T Mitry E	2011	Bull Cancer2011，98，12：	1
6	Genome-wide allelotyping indicates increased loss of heterozygosity on 9 p and 14 q in early age of onset colorectal cancer 显示文摘	Weber T K Conroy J Keitz B	1999	Cyto-genet Cell Genet1999，86，2：	1
7	Clinical and psychomet ric validation of an EORTC questionnaire module,the EORTC QLQ2OES18,to assess quality of life in patient s wit hoesophageal cancer显示文摘	Blazeby JM Conroy T Hammerlid E	2003	Eur J Cancer2003，39，10：	1
8	An open phase I study assess- ing the feasibility of the trple combination:oxaliplatin plus irino- tecan plus leucovorin/5-fluorouracil every 2 weeks in patients with advanced sold tumors显示文摘	Ychou M Conroy T Seitz JF	2003	Ann Oncol2003，14，：	1
9	Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer显示文摘	H Bleiberg T Conroy B Paillot A.J Lacave G Blijham J.H Jacob L Bedenne M Namer P De Besi F Gay L Collette T Sahmoud	1997	European Journal of Cancer1997，，8：	1
10	Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203显示文摘	Gerard JP Conroy T Bonnetain F	2006	J Clin Oncol2006，24，28：	1
11	High dose methotrexate for the treatment of primary cerebal ly-mphomas: analysis of survival and late neurologic toxicity in a retrospective series 显示文摘	Blay JY Conroy T Chevreau C	1998	J Clin Oncol1998，16，3：	1
12	Definitive chemo radiotherapy (CRT) with FOLFOX 4 or 5FU-cisplatin as first line treatment for patients with inoperable esophageal cancer (IEC): Final results of arandomized phase Ⅱ study显示文摘	Conroy T Yataghene Y Etienne P L	2007	J Clin Oncol2007，25，18：	1
13	Development of an EORTC disease-specific quality of life module for use in pa- tients with gastric cancer 显示文摘	Vickery CW Blazeby JM Conroy T	2001	Eur J Cancer2001，37，8：	1
14	Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer 显示文摘	Bleiberg H Conroy T Paillot B	1997	Eur J Cancer1997，33，8：	1
15	Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: Response toxicity quality of life and survival显示文摘	Conroy T Etienne PL Adenis A	2002	Ann Ocol2002，13，5：	1
16	Non-surgical treatments of esophageal cancer显示文摘	Conroy T Kaminsky M C Peiffert D	2000	Rev Med Interne2000，21，1：	1
17	Phase Ⅱ randomised trial ofchemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil inoesophageal cancer显示文摘	Conroy T Yataghène Y Etienne PL	2010	British Journal of Cancer2010，18，：	1
18	FOLFIRINOXversus gemcitabine for metastatic pancreatic cancer显示文摘	CONROY T DESSEIGNE F YCHOU M	2011	N Engl JMed2011，364，19：	1
19	Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203显示文摘	Gerard JP Conroy T Bonnetain F	2006	J Clin Oncol2006，24，28：	1
20	Quality-of-lifefindings from a randomised phase-II study of XELOX vs FOLFOX-6 in metastatic colorectal cancer显示文摘	Conroy T Hebbar M Bennouna J	2010	Br J Cancer2010，102，1：	1

返回顶部每页显示：

共15页首页上一页第1页下一页末页 /15 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示